Toggle navigation
Home
Search
Services
Blog
Contact
About
Development of Tumor Vaccines Using Gpi Linked Molecules
Segal, Andrew H.
Genitrix, LLC, Cambridge, MA, United States
Search 10 grants from Andrew Segal
Search grants from Genitrix, LLC
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Fred Hutchinson Cancer Research Center
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Mechanism of Dynein-Mediated Spindle Positioning
Stochastic Simulation Of Excitation-contraction Coupling
Human Cardiomyopathy and HSP60
Tritium Label Noline & Other B Carbolines
REU: Geochemical and Petrologic Studies of Lavas from the Eastern Indian Ocean: Implications for Mantle Sources and Processes and Constraints on Plate Motions
Recently added grants:
Receptor Cross-Talk in Early Metastatic Dissemination
Investigating PolQ-mediated alternative NHEJ in breast cancer
The physiological role of the cytoplasmic domain of a disintegrin and metalloproteinase 17 (ADAM17)
Fasting Protects Small Intestinal Stem Cells from Lethal DNA Damage: Mechanistic Insight and Preclinical Translation
Regulation of TRP channels and visual transduction
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Small Business Innovation Research Grants (SBIR) - Phase I (R43)
Project #
3R43CA074665-01A1S1
Application #
6021665
Study Section
Special Emphasis Panel (ZRG2 (02))
Program Officer
Reynolds, Craig W
Project Start
1997-09-30
Project End
1999-06-30
Budget Start
1997-09-30
Budget End
1999-06-30
Support Year
1
Fiscal Year
1999
Total Cost
Indirect Cost
Institution
Name
Genitrix, LLC
Department
Type
DUNS #
City
Cambridge
State
MA
Country
United States
Zip Code
02142
Related projects
NIH 1999
R43 CA
Development of Tumor Vaccines Using Gpi Linked Molecules
Segal, Andrew H. / Genitrix, LLC
NIH 1997
R43 CA
Development of Tumor Vaccines Using Gpi-Linked Molecules
Segal, Andrew H. / Genitrix, LLC
Comments
Be the first to comment on Andrew Segal's grant